BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Biologics

Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness

In an exclusive interview with BioPharma APAC, Mr. Brendan O’Callaghan, Executive Vice President, Manufacturing & Supply at Sanofi, sheds light o...

December 09, 2024 | News

NTC Announces Positive Phase II Results for NTC014 in Bacterial Conjunctivitis Treatment

NTC, an international R&D focused pharmaceutical company headquartered in Italy, presents positive results from Phase II MIRAKLE study, a mul...

December 06, 2024 | News

Beckman Coulter Life Sciences Introduces Cydem VT System, Transforming Clone Screening for Biologics

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, and a company of Danaher Corporation (NYSE: DHR), launches the Cyde...

December 05, 2024 | News

Innovent and HUTCHMED Secure Conditional Approval in China for TYVYT® and ELUNATE® Combo in Advanced Endometrial Cancer

Innovent Biologics, Inc. a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...

December 04, 2024 | News

Telix and Grand Pharma Dose First Patient in Phase III ZIRCON-CP Trial for ccRCC Imaging in China

Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) and Grand Pharmaceutical Group Limited (00512.HK, Grand Pharma) announce th...

November 29, 2024 | News

Allink Biotherapeutics Secures $42 Million Series A Funding to Drive Global Expansion of Next-Gen ADC and Bispecific Antibody Therapies

Allink Biotherapeutics, a clinical-stage biotechnology company pioneering next-generation bispecific antibody and antibody-drug conjugate (ADC) therapeutic...

November 29, 2024 | News

Kelun-Biotech Secures China’s First Approval for TROP2-Directed ADC Sacituzumab Tirumotecan for Advanced Triple-Negative Breast Cancer

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company received marketing authorization in China from ...

November 28, 2024 | News

Sanofi Introduces Asia's First Modulus Facility in Singapore, Redefining Biopharma Manufacturing

The facility’s novel concept shortens production timelines and enables rapid changes in production capacities across medicines B...

November 28, 2024 | News

ReviR Therapeutics Secures Kennedy’s Disease Association Grant to Advance Therapy for Rare Neuromuscular Disorder

ReviR Therapeutics, a pioneering biotechnology company focused on developing novel small molecule RNA modulators for neurogenetic diseases, announced a gro...

November 26, 2024 | News

Duality Biologics and Adcendo Expand Collaboration to Strengthen ADC Cancer Therapy Pipeline

Duality Biologics ("Duality"), a clinical-stage biotech company focusing on the discovery and development of next generation antibody-drug conjugate therap...

November 26, 2024 | News

QIAGEN’s QIAcuityDx Digital PCR System Approved by ARTG to Enhance Clinical Diagnostics Across Australia and New Zealand

Provides absolute quantitation, essential for precise monitoring of low-abundance targets in clinical diagnostics Enhances lab effic...

November 26, 2024 | News

ArkBio Completes Phase 1 Enrollment for AK0610, Pioneering RSV Prevention for Vulnerable Infants

Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") announced the successful enrollment and dosing of all participants in a Phase 1 clinical study of AK061...

November 25, 2024 | News

Thermo Fisher Scientific Launches Invitrogen™ Vivofectamine™: Advancing Non-Viral Nucleic Acid Delivery

Thermo Fisher Scientific has announced the launch of the Invitrogen™ Vivofectamine™ Delivery Solutions, an advanced lipid nanoparticle (LNP) te...

November 22, 2024 | News

Bio Usawa and Rwanda Development Board Partner to Launch First Eye Treatment Manufacturing Plant in Rwanda

Bio Usawa and the Rwanda Development Board have partnered to establish Rwanda’s first manufacturing plant for affordable treatments for serious eye...

November 22, 2024 | News

Stay Connected